Insider · CIK 0001827505
Nicole Sweeny
officer
Files at KALV (KalVista Pharmaceuticals, Inc.). First filing Aug 25, 2025, latest Dec 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $96k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 22Weak | KalVista Pharmaceuticals, Inc. | $51k 3,813 shares | -9% | - | |
| 15Weak | KalVista Pharmaceuticals, Inc. | $20k 1,480 shares | -4% | - | |
| 15Weak | KalVista Pharmaceuticals, Inc. | $25k 1,864 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +6,250 | - | - | 38,541 | Dec 4, 2025 |
| Nov 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +5,000 | - | - | 43,541 | Dec 4, 2025 |
| Nov 24, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -3,813 | $13.45 | $51k | 39,728 | Dec 4, 2025 |
| Nov 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,250 | $0.00 | $0 | 81,250 | Dec 4, 2025 |
| Nov 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -5,000 | $0.00 | $0 | 50,000 | Dec 4, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +5,000 | - | - | 33,771 | Aug 26, 2025 |
| Aug 25, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,480 | $13.42 | $20k | 32,291 | Aug 26, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -5,000 | $0.00 | $0 | 55,000 | Aug 26, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Common Stock | +6,250 | - | - | 30,635 | Aug 25, 2025 |
| Aug 22, 2025 | KALV KalVista Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -1,864 | $13.22 | $25k | 28,771 | Aug 25, 2025 |
| Aug 21, 2025 | KALV KalVista Pharmaceuticals, Inc. | MOption exercise Restricted Stock Unitderivative | -6,250 | $0.00 | $0 | 87,500 | Aug 25, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.